comparemela.com

Latest Breaking News On - University health network antimicrobial stewardship program - Page 1 : comparemela.com

What microplastics are doing to seabirds could tell us about their effect on humans

In this week's issue of our environment newsletter, we look at the effect of microplastics on seabirds and how to protect your pets from wildfire smoke.

Portugal
Calgary
Alberta
Canada
Toronto
Ontario
Italy
Geneva
Genè
Switzerland
Canadian
Gloria-fackelmann

The next pandemic: Applying learnings from COVID-19 to tackle Antimicrobial Resistance

/CNW/ - Antimicrobial Resistance (AMR) is considered the silent pandemic and develops when microorganisms such as bacteria and viruses become resistant to.

Canada
Toronto
Ontario
Canadians
Canadian
Health-technology-trends-to
University-of-toronto
Labcandx-coalition
Sinai-health
Laboratory-medicine
Canadian-agency-for-drugs

Ottawa spent $100 million on 'effectively useless' COVID drugs: expert

iPolitics By Charlie Pinkerton. Published on Mar 3, 2021 5:18pm Dr. Andrew Morris, medical director of the Sinai Health System-University Health Network Antimicrobial Stewardship Program, appears before the House of Commons Health committee on Feb. 26, 2020. (Screenshot) The federal government mishandled its procurement of COVID-19 treatments by spending an estimated $100 million on “effectively useless” drugs, says the doctor who runs a program that advises two Toronto hospital networks about medications. In the fall, Ottawa announced major purchases of two drugs, remdesivir and bamlanivimab, shortly after Health Canada approved them to treat people with COVID. On Sept. 20, the government announced it had bought 150,000 vials of remdesivir, but not how much it paid for them. But based on the US$390-per-vial price set by Daniel Day, the CEO of Gilead Sciences, which sold the drug to Ottawa, it can be estimated that Canada paid around $77 million for the batch, whi

Canada
Toronto
Ontario
Ottawa
Canadian
Patty-hajdu
Daniel-day
Andrew-morris
Gilead-sciences
National-advisory-committee-on-immunization
World-health-organization
House-of-commons-health

Evening Brief: Jab campaign could ramp up

iPolitics By iPolitics. Published on Mar 3, 2021 5:53pm The first doses of the Oxford-AstraZeneca COVID-19 vaccine arriving in Canada on March 3 (Bill Blair via Twitter) Today’s Evening Brief is brought to you by Internet Society Canada Chapter. This Thursday, join us for a discussion about a new Angus Reid Institute poll on Canadians’ experiences using government digital platforms and their expectations of government digital transformation. Register now. Good evening to you. It’s wheels down for the first doses of the Oxford-AstraZeneca vaccine against COVID-19. Nearly 500,000 doses arrived in Canada earlier today, but there’s still some confusion about whose arms they should enter. Health Canada last week authorized its use for all adult Canadians, but the National Advisory Committee on Immunization recommended earlier this week that it not be administered to people age 65 or older. Other countries, including France, have since moved on from that position an

China
New-york
United-states
Texas
White-house
District-of-columbia
Vancouver
British-columbia
Canada
Phoenix
Arizona
Toronto

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.